Arrowhead Pharmaceuticals Inc (ARWR)
22.53
-1.15
(-4.86%)
USD |
NASDAQ |
Apr 17, 16:00
22.53
0.00 (0.00%)
After-Hours: 16:37
Arrowhead Pharmaceuticals Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.0243 |
June 30, 2018 | 0.0232 |
March 31, 2018 | 0.0213 |
December 31, 2017 | 0.0351 |
Date | Value |
---|---|
September 30, 2017 | 0.0311 |
June 30, 2017 | 0.0287 |
March 31, 2017 | 0.028 |
December 31, 2016 | 0.0274 |
September 30, 2016 | 0.0285 |
June 30, 2016 | 0.0455 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.0003 |
June 30, 2014 | 0.0003 |
March 31, 2014 | 0.0055 |
December 31, 2013 | 0.0127 |
September 30, 2013 | 0.0371 |
June 30, 2013 | 0.0279 |
March 31, 2013 | 0.1751 |
December 31, 2012 | 0.1098 |
September 30, 2012 | 0.0938 |
June 30, 2012 | 0.0847 |
March 31, 2012 | 0.0611 |
December 31, 2011 | 0.0435 |
September 30, 2011 | 0.0474 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 626.29M |
Total Liabilities (Quarterly) | 452.57M |
Shareholders Equity (Quarterly) | 160.41M |
Current Ratio | 3.733 |